Please login to the form below

Not currently logged in
Email:
Password:

health technology assessment

This page shows the latest health technology assessment news and features for those working in and with pharma, biotech and healthcare.

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

Unsure on efficacy, NICE passes J&J’s Darzalex to CDF

measure. The UK’s health technology assessment agency rejected Darzalex (daratumumab) as a third-line treatment for patients with multiple myeloma last March, to the consternation of the company and patients ... The financial terms of the agreement are

Latest news

  • Transforming access in rare diseases Transforming access in rare diseases

    Health Technology Assessment (HTA) is an essential component of the introduction and reimbursement of new medicines - not just in the United Kingdom (with bodies such as NICE, the SMC and AWMSG) - ... From IQWiG in Germany to the HAS in France and the

  • Duchenne UK and pharma partner pilot data-sharing HTA approach Duchenne UK and pharma partner pilot data-sharing HTA approach

    for generating health technology assessment (HTA) data used in reimbursement decisions. ... reach regulatory approval; how we get governments and health services to pay for these medicines, ”said the charity.

  • Spark sets Luxturna price, igniting US affordability debate Spark sets Luxturna price, igniting US affordability debate

    We believe that access to therapy is a shared responsibility among Spark Therapeutics, payers, health benefit providers, physicians and treatment centres, ”commented Marazzo. ... The biotech has previously drawn comparisons with GlaxoSmithKline’s

  • NICE set to reject wider use of Eisai’s Halaven NICE set to reject wider use of Eisai’s Halaven

    The UK health technology assessment agency says there is a lack of evidence that Halaven offers value for money in locally-advanced or secondary breast cancer in patients who have previously

  • EMA forges closer ties with HTA umbrella group EMA forges closer ties with HTA umbrella group

    EMA forges closer ties with HTA umbrella group. Agrees joint work plan with the European Network for Health Technology Assessment. ... The EMA has extended a partnership with the organisation representing Europe’s health technology assessment (HTA)

More from news
Approximately 1 fully matching, plus 158 partially matching documents found.

Latest Intelligence

  • Drug pricing

    Healthcare terms - Drug pricing.

  • Medical education

    Healthcare terms - Medical education.

  • Market access

    Healthcare terms - Market access.

  • The gold standard of scientific evidence The gold standard of scientific evidence

    Because of the perceived quality of clinical trials data, RCT data is used in most health technology assessment (HTA) appraisals around the world; in 2015, 90% of CADTH appraisals, 80% of ... Health insurance claims and electronic medical records

  • Patient involvement in health technology assessment Patient involvement in health technology assessment

    Patient involvement in health technology assessment. Patients can improve the quality, relevance and value of HTA for all pharma stakeholders. ... Neil Bertelsen, chair of Health Technology Assessment’s (HTAi) Patient and Citizen Involvement in HTA

More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest appointments

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and health economics expertise allows us to

  • EFPIA's Richard Torbett to move to the ABPI EFPIA's Richard Torbett to move to the ABPI

    with the Department of Health around the PPRS.”. ... At the ABPI Torbett will focus on pricing, the Pharmaceutical Price Regulation Scheme (PPRS), health technology assessments (HTA) and value assessment, as well as market access in the UK.

  • ABPI appoints value and access manager ABPI appoints value and access manager

    Rowland will work on a range of projects to improve patient access to innovative medicines, in line with the ABPI's strategic objectives around health technology assessment and market access. ... I am delighted to join the ABPI at this time of great

  • Former NICE chair joins board of biotech Former NICE chair joins board of biotech

    I no longer have anything to do with [NICE],” he told the FT, clarifying his future influence on the health technology assessment (HTA) body. ... His expertise in the cost-effectiveness of new pharmaceuticals and other issues in health economics will

  • Access Partnership expands its senior team Access Partnership expands its senior team

    His international experience extends to product development and commercialisation, health economics, health outcomes research, health technology assessment, market access and pricing strategies.

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Navigating the way to a positive HTA: avoiding snakes, climbing ladders

    Hayward Medical Communications reports on how industry can avoid the ‘ snakes’ by climbing strategic ‘ ladders’ to achieve health technology assessment success. ... Health technology assessment (HTA) outcomes can make, or break, a product’ s

  • Journal sponsorship

    In tandem with its publishing activities over 25 years, Hayward – unlike other medical publishers – is a highly successful medical communications agency that submits evidence on behalf of healthcare companies to ... technology assessment bodies,

  • Unique forum will unite NHS and industry to drive innovation

    Guests can find out about partnership working approaches through collaboration with Academic Health Science Networks (AHSNs) too. ... industry that’ s required to deliver an ambitious programme of transformation ·. Clarity on the role of NICE and

  • Navigating the way to a positive HTA: avoiding snakes, climbing ladders

    Hayward Medical Communications reports on how industry can avoid the ‘ snakes’ by climbing strategic ‘ ladders’ to achieve health technology assessment success. ... Health technology assessment (HTA) outcomes can make, or break, a product’ s

  • Hayward Medical Communications

    Hayward Medical Communications reports on how industry can avoid the ‘ snakes’ by climbing strategic ‘ ladders’ to achieve health technology assessment success. ... They have facilitated advisory boards, Health Technology Assessment submissions

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics